| 2026-11 est. | P2 | BioNTech SE BNTX | NCT04486378 A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage I | Colorectal Cancer Stage II; Colorectal Cancer Stage III | active not recruiting | 327 |
| 2026-09-22 | P3 | BioNTech SE BNTX | NCT07300839 A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | COVID-19; SARS-COV-2 Infection | completed | 5240 |
| 2026-07-24 | P3 | BioNTech SE BNTX | NCT07222384 A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe C | COVID-19; SARS-COV-2 Infection | completed | 344 |
| 2026-07-10 | P3 | BioNTech SE BNTX | NCT05543616 A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children | SARS-CoV-2 Virus; Severe Acute Respiratory Syndrome Coronavirus 2; COVID-19 | completed | 4338 |
| 2026-05-01 | P3 | BioNTech SE BNTX | NCT07069309 A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher | COVID-19; SARS-COV-2 Infection | completed | 774 |
| 2026-03-12 | P1/P2 | BioNTech SE BNTX | NCT05547464 Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers | Tuberculosis | active not recruiting | 497 |
| 2025-12-22 | P1/P2 | BioNTech SE BNTX | NCT05262530 Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors | Solid Tumor | terminated | 73 |
| 2025-12-17 | P1/P2 | BioNTech SE BNTX | NCT06821061 A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People | Influenza; COVID-19 (Coronavirus Disease 2019) | completed | 2650 |